SCHEMBL6359338

SCHEMBL6359338

[c]1nc(CCc2ccccc2)nc2scc(-c3ccccc3)c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.38
NOS1 P29475 1/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
LMNA P02545 5/20 0.35
ALDH1A1 P00352 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
HTT P42858 1/20 0.34
DAPK3 O43293 1/20 0.34
PRKD3 O94806 1/20 0.34
MAP4K4 O95819 1/20 0.34
ABL1 P00519 1/20 0.34
NTRK1 P04629 1/20 0.34
LCK P06239 1/20 0.34
CSF1R P07333 1/20 0.34
RET P07949 1/20 0.34
MET P08581 1/20 0.34
PDGFRB P09619 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6364115 0.91 HTT (0.41) SMN1; SMN2LMNAALDH1A1MEN1KMT2A
SCHEMBL5789263 0.85 HSD17B10 (0.40) SMN1; SMN2LMNAALDH1A1MEN1KMT2A
SCHEMBL6359795 0.83 ALDH1A1 (0.42) ESR1SMN1; SMN2LMNAALDH1A1MEN1
SCHEMBL5790639 0.83 HTT (0.35) SMN1; SMN2LMNAALDH1A1MEN1KMT2A
SCHEMBL6359949 0.76 SQOR (0.37) ESR1SMN1; SMN2LMNAALDH1A1MEN1
SCHEMBL2369472 0.76 MEN1 (0.44) ESR1MEN1KMT2AGSK3AGSK3B
SCHEMBL6364382 0.76 ESR1 (0.45) ESR1SMN1; SMN2LMNAALDH1A1KDM4E
SCHEMBL5788978 0.73 STAT3 (0.37) SMN1; SMN2LMNAALDH1A1MEN1KMT2A
SCHEMBL5789324 0.72 FGFR1 (0.35) ESR1SMN1; SMN2LMNAALDH1A1KDM4E
SCHEMBL6362941 0.72 MAPT (0.38) SMN1; SMN2LMNAALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050026935-A1 Compounds XENTION DISCOVERY LTD. 2005-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026935-A1 Compounds KCNJ11, KCNJ1, KCNH1 ESR1 4494/4885NOS1 1963/4885SMN1; SMN2 1520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.